Press Releases

May 9, 2017

First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T-Cell Immunotherapy

Phase 1 pilot study utilizes T-cell antigen presenting cells to prolong the persistence of cancer-fighting chimeric antigen receptor (CAR) T cells, reduce the relapse rate. After […]
June 2, 2016

Seattle Children’s T-Cell Immunotherapy Clinical Trial for Children With Relapsed Leukemia Shows 93% Complete Remission Rate

Phase 1 findings show 39 out of 42 patients achieved complete remission; Phase 2 of the trial to launch this month Seattle Children’s announced today that […]
December 21, 2015

Jude Gets a New Chance at Life, Thanks to Groundbreaking Research and Financial Support from People Across the Country

Donations from all 50 states are helping expedite immunotherapy research that scientists believe has the ability to cure childhood cancer. Aidan and Barbara Anderson of Tucson, […]
November 7, 2015

Seattle Children’s Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91 Percent Complete Remission Rate in Children with Relapsed Leukemia

Of the 22 patients treated, 20 responded to the treatment and achieved complete remission. Seattle Children’s announced today that 20 of 22 patients treated thus far […]
December 2, 2014

$100 Million Fundraising Initiative – Strong Against Cancer – Launches with Goal of Curing Childhood Cancer

Donations will support Seattle Children’s immunotherapy research trials that have spurred remission in patients who had little to no hope for recovery. Seattle Children’s Hospital and […]
November 6, 2014

Seattle Children’s Begins Recruiting Patients for Immunotherapy Research Trial for Neuroblastoma, One of the Deadliest Forms of Childhood Cancer

Seattle Children’s today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed to induce remission in children suffering from neuroblastoma, […]
November 6, 2014

Seattle Children’s Begins Recruiting Patients for Immunotherapy Research Trial for Neuroblastoma, One of the Deadliest Forms of Childhood Cancer

Seattle Children’s today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed to induce remission in children suffering from neuroblastoma, […]